C Test Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 49.35%
- Profit Growth 55.80%
- Ebitda 57.12%
- Net Worth -2.38%
- Total Assets 0.25%
About C Test Medicals
C Test Medicals Private Limited (CTMPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 2012 and has a history of 12 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Ali Irani, Mir Ali, and Ali Ettehad serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100MH2012PTC231323
-
Company No.
231323
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 May 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at C Test Medicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ali Ettehad
|
Director | 15-Jan-2022 | Current |
|
Ali Irani
|
Director | 01-Apr-2019 | Current |
|
Mir Ali
|
Director | 30-Jun-2017 | Current |
Financial Performance of C Test Medicals.
C Test Medicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.35% increase. The company also saw a substantial improvement in profitability, with a 55.8% increase in profit. The company's net worth dipped by a decrease of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of C Test Medicals?
In 2023, C Test Medicals had a public holding of 5.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ciel Food Trade Private LimitedAli Irani is a mutual person
-
-
Dr. Ali Irani Health Care Private Limited
Ali Irani is a mutual person
-
Benevolent Constructions Private Limited
Ali Ettehad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at C Test Medicals?
Unlock and access historical data on people associated with C Test Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of C Test Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped C Test Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
